|
Sign In to gain access to subscriptions and/or personal tools.
|
Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits
Jianhua Zhu
Department of Cardiology, First Affiliated Hospital, Medical School, Zhejiang University, China
Danchen Gao
Department of Cardiology, First Affiliated Hospital, Medical School, Zhejiang University, China, Gaodc@ mail.hz.zj.cn
Intimal thickening and formation of extracellular matrix are parts of the repair process after vascular injury. Similar processes occur after coronary angioplasty. Prior studies have shown that losartan inhibits intimal thickening in rat carotid arteries following balloon injury. However, the effects of losartan in reducing the collagen content of arteries after balloon injury have not been examined. The objectives of this study were to determine the change in collagen content after balloon injury and to analyse the mechanisms of reduction of collagen content and intimal thickening. Losartan (15 mg/kg/d) was administered orally from six days before to eight weeks after balloon injury in rabbits. Collagen content was measured histologically by the use of circularly polarised images of picrosirius red-stained sections. Collagen content in arterial intima was found to be significantly lower in the losartan-treated group (n=12) than in the control group (n=12) (21.6%±5.2% vs. 43.8%±7.6%, p<0.01). Losartan reduced the collagen content in arterial intima by 50.7% area fraction compared with that of control. The morphological observation showed that the intimal area and intimal-to-medial area ratio in the losartan-treated group were significantly less than in the control group (0.27±0.13mm 2 vs. 0.52±0.29 mm2, 0.55±0.21 vs. 0.97±0.25, respectively, p<0.05). These data indicate that losartan reduces vascular collagen content and inhibits intimal thickening after balloon injury. The results also suggest that collagen accumulation in the intima may be an important factor in the development of the stenotic lesion and that the use of losartan may have therapeutic value to prevent stenosis after balloon injury.
Key Words: nonpeptide angiotensin II receptor antagonist • losartan • extracellular matrix • collagen • intimal thickening • balloon injury • stenosis
References
- Ming WL, Roubin GS, King S. et al. Restenosis after coronary angioplasty:potential biologic determinants and role of intimal hyperplasia. 1989; 79(6): 1374-87.
- Clowes AW, Reidy MA, Clowes MM Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49: 208-15.[Web of Science][Medline]
[Order article via Infotrieve]
- Strauss BH, Chisholm RJ, Keeley FW et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994; 75:650-8.[Abstract/Free Full Text]
- Forester JS, Fishbein M., Helfant R. et al. A Paradigm for restenosis based on cell biology: Clues for the development of new preventative therapies. J Am Coll Cardiol 1991; 17: 759-69.
- Isner JM, Kearney M., Bortman S. et al.Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-11.[Abstract/Free Full Text]
- Tardif JC, Cote G., Lesperance J. et al. Probucol and multi-vitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997; 337: 365-72.[Abstract/Free Full Text]
- Lindner V., Fingerle J., Reidy MA Mouse model of arterial injury. Circ Res 1993; 73:792-6.[Abstract/Free Full Text]
- Olsen NE, Chao S., Lindner V. et al. Intimal smooth muscle cell proliferation after balloon catheter injury:The role of basic fibroblast growth factor. Am J Pathol 1992; 140: 1017-23.[Abstract]
- Mintz GS, Kovach JA, Pichard AD et al. Geometric remodeling is the predominant mechanism of clinical restenosis after coronary angioplasty. J Am Coll Cardiol 1994; 23: 138A.
- Schwartz RS, Holmes DR, Topol EJ The restenosis paradigm revisited:An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-93.[Abstract]
- Margaret FP, Randy L., Webb et al. Angiotensin-converting enzyme inhibiter versus angiotensin II,AT1-receptor antagonist: Effects in smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 1991; 139(6): 1291-6.[Abstract]
- Itoh H., Mukoyama M., Pratt RE et al. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268.[Web of Science][Medline]
[Order article via Infotrieve]
- Itoh H., Pratt RE, Gibbons G. et al.Angiotensin II modulate proliferation of vascular smooth muscle cells via autocrine loops of TGF-beta and bFGF. Hypertension 1991;18: 396.
- Zhaoqiang C., Xi CH, Wenjiang CH et al. Relation of the transcription and regulation of type I angiotensin II receptor gene with myocardial remodeling in rats. Chin J Cardiol 1999; 27(4): 307-10.
- Suzuki J., Matsubara H., Urakami et al. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993; 73: 439-47.[Abstract/Free Full Text]
- Raymond F., Kauffman, James S et al. Losartan, a nonpeptide angiotensin II receptor antagonist, inhibits neointimal formation following balloon injury to rat carotid arteries. Life Science 1991; 49: 223-8.
- Baumgartner HR The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5:167.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Junquiere LCU, Bignolas G., Brentani RR Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochemical J 1979; 11: 447.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hiroshi A., Yasunari N., Hidehisa H. Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, Losartan. Br J Pharmacol 1992; 106: 665-71.[Web of Science][Medline]
[Order article via Infotrieve]
- Yang SY, Hu ZY, Cao H. et al. Effects of angiotensin II receptor antagonist on renin-angiotensin system in main organs of spontaneously hypertensive rats. Chinese Circulation J 2000; 15(1): 56-8.
- Kenji M., Makio T. Shigeatsu H. et al. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Life Science 1992; 51: pp: 367-74.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Miao LY, Jiang WP Effects of valsartan on the angiotensin II levels and ventricular remodeling. Chin J Cardiol 1999; 27(6): 456-8.
- Steckelings V., Levrum C. Role of brain angiotensin in cardiovascular regulation.JCardiovas Pharmacol 1992; 19(Suppl 16): S73-9.
- Caulfield M., Lavender P., Newell PJ et al. Angiotensinogen in human essential hypertension. Hypertension 1996; 28(6): 1123-5.[Abstract/Free Full Text]
- Eggena P., Barrett JD Regulation and functional consequences of angiotensin gene expression. J Hypertens 1992; 10: 1063-8.[Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 3,
278-282 (2000)
DOI: 10.3317/jraas.2000.043
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
